CD19 and neoplasm: Previous work by Brentjens and colleagues12 showed eradication of 106 EL4 tumor cells expressing human CD19 in transgenic C57BL6(mCD19−/−hCD19+/−) with a first generation anti-human CD19 CAR expressing murine IL-12.